why is tirzepatide dose higher than semaglutide Switching to Mounjaro vs. Ozempic: Effectiveness, Side

We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials

Curr Opin Rheumatol (2015) 27(5):45460

Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have shown unprecedented success in helping individuals lose significant amounts of weight, often rivaling the results of bariatric surgery

ALT and AST: Expected Trajectory on Ipamorelin In clinical practice at compounding-pharmacy dose ranges (100 to 300 mcg subcutaneous, given 1 to 3 times daily), ALT and AST values typically remain within the normal reference range

While this isnt unique to GLP-1s, it does underscore the idea that todays GLP-1sand, by extension, those in developmentdont work for everyone